Filing Details
- Accession Number:
- 0001209191-16-134702
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-01 18:43:58
- Reporting Period:
- 2016-07-29
- Filing Date:
- 2016-08-01
- Accepted Time:
- 2016-08-01 18:43:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1299130 | Pacific Biosciences Of California Inc. | PACB | Laboratory Analytical Instruments (3826) | 161590339 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1504238 | Michael James Phillips | Pacific Biosciences Of California, Inc. 1380 Willow Road Menlo Park CA 94025 | Svp, Research & Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-07-29 | 17,500 | $1.96 | 198,949 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-07-29 | 2,500 | $2.18 | 201,449 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-07-29 | 20,000 | $8.45 | 181,449 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2016-07-29 | 17,500 | $0.00 | 17,500 | $1.96 |
| Common Stock | Stock Option (right to buy) | Disposition | 2016-07-29 | 2,500 | $0.00 | 2,500 | $2.18 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-06-21 | No | 4 | M | Direct | |
| 97,500 | 2014-02-15 | 2023-02-15 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- This is the weighted average price of the shares sold, which ranged from $8.29 to $8.60 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- 100% of the shares subject to the option were fully vested and exercisable.
- 1/5th of the shares subject to the option vested on February 15, 2014 and the balance of the shares vest monthly thereafter over the next four years, provided that the Reporting Person continues to serve through each vesting date.
Billionaire Hedge Funds
